Close
ACHEMA MIDDLE EAST 2026

Zimmer Biomet Announces FDA Approval of Gel-One Cross-Linked Hyaluronate

Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare announced that the U.S. FDA approved an expanded 26-week efficacy claim for its...

Live broadcast of session on biosimilars and EU regulation: still time to join us!

On February 8th, the EDQM will hold a dedicated session jointly organised with the European Medicines Agency on the role of the European Pharmacopoeia...

AMRA announces $9 million investment from Pfizer Venture Investments, Novo Seeds and Industrifonden

Swedish-based digital health company AMRA has announced a $9 million funding round co-led by US-based Pfizer Venture Investments and leading Nordic VC Novo Seeds....

Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications

Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM, the first commercially available...

Johnson Matthey Fine Chemicals launches new online catalyst store

The store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts, to accelerate development of...

TOT BIOPHARM and LEE’S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug

TOT BIOPHARM Co Ltd. and LEE'S PHARMACEUTICAL HOLDINGS LIMITED jointly announced that LEE'S PHARM, through its wholly-owned subsidiary Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited has...

Senhwa Biosciences gets Orphan Drug Designation from US FDA for CX-4945

Senhwa Biosciences, Inc. announced that the U.S. FDA has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma.        ...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...